Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STELAR: Short DAPT With Low-Dose Ticagrelor vs Standard DAPT With Clopidogrel After PCI in Chronic Coronary Syndrome
2026-526368-18-00Phase 3Authorised
- Sponsor
- Azienda Ospedaliera Universitaria Gaetano Martino
- Start
- Jul 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ticagrelor, clopidogrel and aspirin in Chronic Coronary Syndrome (CCS) and coronary arteriosclerosis (2 arms), sponsored by Azienda Ospedaliera Universitaria Gaetano Martino. Primary endpoint: Net adverse clinical events (NACE). Planned start Jul 2026; status: authorised.
02
Drugs
ticagrelorclopidogrelaspirin
03
Conditions
Chronic Coronary Syndrome (CCS)coronary arteriosclerosis
Beyond the preview
Go deeper on 2026-526368-18-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-526368-18-00.